| 1 |
34411609 | Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells. | 2021 Oct 1 |
2 |
| 2 |
29881562 | A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B). | 2018 Jun |
2 |
| 3 |
24266751 | Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts. | 2014 Mar 1 |
1 |
| 4 |
19399896 | Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. | 2009 Jul 1 |
2 |
| 5 |
24692796 | Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients. | 2008 Apr |
1 |
| 6 |
16137227 | Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. | 2005 Aug |
1 |
| 7 |
10649686 | The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. | 1998 |
2 |
| 8 |
2556907 | MR imaging of the brain in patients with mucopolysaccharidosis. | 1989 Nov-Dec |
1 |
| 9 |
6240800 | Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome. | 1984 Nov |
1 |
| 10 |
6402508 | Utilization of exogenously added acetyl coenzyme A by intact isolated lysosomes. | 1983 Mar 10 |
1 |